Page last updated: 2024-10-18

dihydroxyphenylalanine and Acute Hypercapnic Respiratory Failure

dihydroxyphenylalanine has been researched along with Acute Hypercapnic Respiratory Failure in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hunter, KR1
Stern, GM1
Sharkey, J1
Paulson, GD1
Tafrate, RH1

Other Studies

2 other studies available for dihydroxyphenylalanine and Acute Hypercapnic Respiratory Failure

ArticleYear
Levodopa in postencephalitic parkinsonism.
    Lancet (London, England), 1970, Dec-26, Volume: 2, Issue:7687

    Topics: Dihydroxyphenylalanine; Humans; Mental Disorders; Movement Disorders; Parkinson Disease, Postencepha

1970
Some "minor" aspects of parkinsonism, especially pulmonary function.
    Neurology, 1970, Volume: 20, Issue:12

    Topics: Dihydroxyphenylalanine; Humans; Lung; Parkinson Disease; Respiration; Respiratory Function Tests; Re

1970